Skip to content
  • Saturday, 30 May 2026
  • 2:18 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
Pharmaceutical R&D

Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease

Teuku Ryan May 30, 2026 0

Sanofi has secured a significant milestone in its development of venglustat, an innovative oral glucosylceramide synthase inhibitor (GCSi), with the…

Read More
Rethinking Artificial Intelligence in Cognitive Science as New Research Challenges the Centaur ModelHealing Skin Without Scarring May Be Possible, As Researchers Unblock Embryonic Regrowth Mechanism in Mice.Shock waves in the early universe may have helped matter reign supremePyjanitor Revolutionizes Python Data Cleaning with Elegant Method Chaining for Enhanced Efficiency and Readability
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Decoding the Inflammatory Landscape of the Bone Marrow Niche and Its Role in the Pathogenesis of Myeloid MalignanciesTop Pharma Companies Set Sustainability Goals, But Emissions Are Still IncreasingScientists Stabilize Elusive Transitional State of Matter Using Nanoparticle Superlattices for Quantum AdvancementsSanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Decoding the Inflammatory Landscape of the Bone Marrow Niche and Its Role in the Pathogenesis of Myeloid Malignancies
Dwi Wanna May 30, 2026
Laboratory Automation & Robotics
Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing
Lana Keisha May 30, 2026
Advanced Materials Science
Scientists Stabilize Elusive Transitional State of Matter Using Nanoparticle Superlattices for Quantum Advancements
Nila Kartika Wati May 30, 2026
Pharmaceutical R&D
Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
Teuku Ryan May 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ